Winners of 2017 MENA Green Building Awards honored

Winners of the 2017 MENA Green Building Awards
Updated 24 May 2017

Winners of 2017 MENA Green Building Awards honored

Emirates Green Building Council (EmiratesGBC), an independent forum aimed at conserving the environment by strengthening and promoting green building practices, has announced the winners of the 2017 MENA Green Building Awards that recognize innovation, creativity and excellence in promoting sustainability best practices.
With record submissions from six nations across the MENA region, the awards highlighted the growing focus of industry stakeholders to promote innovation and best practices to drive sustainable built environments.
At a carbon-neutral awards ceremony held at Roda Al-Murooj hotel in Dubai, the winners in various professional categories were honored in the presence of government officials, industry leaders, representatives of academia and media. The Dr. Owainati Student Excellence Award for a student from a university in the UAE, who has conducted exceptional research on a subject related to green building in the Middle East, was also presented at the event.
Enas Alkhateeb, Faculty of Engineering and IT, British University in Dubai, UAE, received the honor for “Potentials of Retrofitting the Federal Buildings in the UAE to Net Zero Electricity Cost Buildings.”
Supported by the World Green Building Council (WorldGBC), the 2017 MENA Green Building Awards was organized by EmiratesGBC in partnership with the JordanGBC and LebanonGBC. The event was highlighted on social media under the hashtag: #MENAGBAwards.
Saeed Al-Abbar, chairman of EmiratesGBC, said: “We congratulate the winners of the 2017 MENA Green Building Awards not only for their demonstrated excellence in driving the sustainable built environment of the region but also for their commitment and dedication to innovation and promoting green best practices. This year, we had a record number of submissions, underlined by their quality, creativity and original thinking.”
Lee Siang, chairman of WorldGBC, added: “The 2017 MENA Green Building Awards highlights the dedication of the regional construction industry stakeholders to pursue environment-friendly practices.
The innovations and best practices that the winners present are uniquely suited for the region and can be replicated in similar environments globally. This makes the awards a key part in the global sustainability narrative that the World Green Building Council promotes.”


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.